New Evolution Ventures Company Profile
Based in Northern California, New Evolution Ventures (NeV) is a private equity firm focused on acquisition, development, management and operation of fitness, media and sports entities both domestically and internationally. Co-Founded in 2008 by Mark Mastrov, Jim Rowley and Mike Feeney, the current team of NeV professionals is shaping the world of fitness, media, and sports one brand at a time. With a foundation representing over a century of business experience, NeV currently has operations and investments in over 20 countries worldwide. For more information, please visit www.newevolutionventures.com.
News Articles
HemaQuest Pharmaceuticals, Inc.: Series B $13M
HemaQuest Pharmaceuticals (San Diego,CA) a clinical-stage small molecule company focused on hemoglobin disorders such as sickle cell disease and beta thalassemia closed a $13M Series B financing, brin...
Avedro in Series D financing for $43 million
Avedro announced the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Point. Avedro’s other investors include Prism Venture Works, De Nov...
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Longitudinal sampling is used to map the evolution of an HIV-1 virus from the time of infection, and the co-evolution of a broadly neutralizing antibody in the same infected patient; the findings have...
By simulating 25,000 generations of evolution within computers, Cornell University engineering and robotics researchers have discovered why biological networks tend to be organized as modules - a find...
Renal Ventures Expands Partnership with Atlantic Health System
LAKEWOOD, Colo.—Renal Ventures Management acquired a majority interest in two chronic care dialysis clinics in Morris County, New Jersey. The acquisition will be structured as a joint venture (JV) b...
Renal Ventures Management Expands Partnership Acquires Two Dialysis Clinics
LAKEWOOD, Colo. — Renal Ventures Management acquired a majority interest in two chronic care dialysis clinics in Morris County, N.J. The acquisition will be structured as a joint venture between Ren...
Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance
The authors review new tools for studying the evolution of antibiotic resistance, including approaches to evolve resistance in the laboratory and analysis of clinical samples. Insights into pathways o...
Lightstone raises a fund of at least $200 million
SAN FRANCISCO, Sept 24 (Reuters) - Lightstone Ventures, a firm formed by life-sciences partners at Morgenthaler Ventures and Advanced Technology Ventures, is raising a fund of at least $200 million....
Drugs and Medications
B4 Brands: Avant EX Instant Hand Sanitizer
Avant foaming hand sanitizer [B4 Ventures LLC]
B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free
Avant original instant hand sanitizer [B4 Ventures LLC]
B4 Brands: Avant Original Instant Hand Sanitizer
Aterra antibacterial hand wash [B4 Ventures LLC]
B4 Brands: Aterra Antibacterial Hand Soap
Avant original - fragrance free [B4 Ventures LLC]
B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer
PubMed Articles
A review of telemedicine business models.
Abstract Telemedicine has become an increasingly popular option for long-distance/virtual medical care and education, but many telemedicine ventures fail to grow beyond the initial pilot stage. Studyi...
CEE-ing is believing: Bioscience ventures in Central and Eastern Europe.
Bioscience ventures in Central and Eastern Europe are becoming a presence in world healthcare markets despite a perennially short supply of venture funding and other support mechanisms relative to oth...
Vision in Venture: Angels of innovation.
Convincing someone to risk money is often the first tangible evidence that a new technology has real market potential. While there's no shortage of impressive new technologies or startups in Israel to...
Interactive games to promote behavior change in prevention and treatment.
Guest Editorial of TEB-2011-0678, "Meeting the Need for Regenerative Therapies: Translation-Focused Analysis of US Regenerative Medicine Opportunities in Cardiovascular and Peripheral Vascular Medicin...
Clinical Trials
Evaluation of Trinity Evolution in Patients Undergoing Ankle Fusion
The purpose of this study is to utilize Trinity Evolution as a graft source in tibiotalar arthrodesis and to follow the subjects to measure the clinical outcomes and fusion rate. The hypot...
Trinity Evolution in Anterior Cervical Disectomy and Fusion (ACDF)
The purpose of this study is to utilize Trinity Evolution in conjunction with an interbody spacer and supplemental anterior fixation of the surgeon's choice and to follow the patients to m...
Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent
The purpose of the EVOLVE Trial is to assess the safety and performance of the everolimus-eluting Evolution stent for the treatment of a de novo atherosclerotic lesion of up to 28 mm in le...
Angio-Seal Evolution Device Registry
Collect data on the use of the Angio-Seal Evolution Device in diagnostic and interventional patient populations.
Evolution of Pain From Herpes Zoster
Evolution of pain and neural injury will be evaluated at 2 years or longer after the onset of AHZ by multiple measures. Assessments at 2 years or longer will be compared to those collected...
Companies
Based in Northern California, New Evolution Ventures (NeV) is a private equity firm focused on acquisition, development, management and operation of fitness, media and sports entities both domesticall...
Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing Chemotype Evolution. Carmot has licensed the technology and fragment librari...
Founded in 2003, Jina Ventures is a New York-based private equity and M&A advisory firm. Over the past 6 years, Jina Ventures has grown into a full service private equity practice, with both principal...
Pappas Ventures, our sole focus is investing in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Our success, however, is not simply...
Residex Ventures provides capital and expertise to accelerate market traction for technology companies. The focus is private equity from start-up to pre-listing phases of innovative European and North...
More Information about "New Evolution Ventures" on BioPortfolio
We have published hundreds of New Evolution Ventures news stories on BioPortfolio along with dozens of New Evolution Ventures Clinical Trials and PubMed Articles about New Evolution Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of New Evolution Ventures Companies in our database. You can also find out about relevant New Evolution Ventures Drugs and Medications on this site too.
